Current consensus guidelines for treatment of neurocysticercosis.

Nash, Theodore E.; Correa, Dolores; Tsang, Victor C. W.; Gilman, Robert Hugh; Martinez, S. Manuel; Sarti, Elsa; White, A. Clinton; Takayanagui, Osvaldo M.; Botero, David; Del Brutto, Oscar H.; García Lescano, Héctor Hugo; Rajshekhar, Vedantam; Allan, James C.; Friedland, Jon S.; Flisser, Ana; Evans, Carlton Anthony William; Schantz, Peter M.; Gonzalez Zariquiey, Armando Emiliano

dc.contributor.author	García Lescano, Héctor Hugo
dc.contributor.author	Evans, Carlton Anthony William
dc.contributor.author	Nash, Theodore E.
dc.contributor.author	Takayanagui, Osvaldo M.
dc.contributor.author	White, A. Clinton
dc.contributor.author	Botero, David
dc.contributor.author	Rajshekhar, Vedantam
dc.contributor.author	Tsang, Victor C. W.
dc.contributor.author	Schantz, Peter M.
dc.contributor.author	Allan, James C.
dc.contributor.author	Flisser, Ana
dc.contributor.author	Correa, Dolores
dc.contributor.author	Sarti, Elsa
dc.contributor.author	Friedland, Jon S.
dc.contributor.author	Martinez, S. Manuel
dc.contributor.author	Gonzalez Zariquiey, Armando Emiliano
dc.contributor.author	Gilman, Robert Hugh
dc.contributor.author	Del Brutto, Oscar H.
dc.date.accessioned	2022-10-25T19:54:09Z
dc.date.available	2022-10-25T19:54:09Z
dc.date.issued	2002
dc.identifier.uri	https://hdl.handle.net/20.500.12866/12453
dc.description.abstract	Taenia solium neurocysticercosis is a common cause of epileptic seizures and other neurological morbidity in most developing countries. It is also an increasingly common diagnosis in industrialized countries because of immigration from areas where it is endemic. Its clinical manifestations are highly variable and depend on the number, stage, and size of the lesions and the host's immune response. In part due to this variability, major discrepancies exist in the treatment of neurocysticercosis. A panel of experts in taeniasis/cysticercosis discussed the evidence on treatment of neurocysticercosis for each clinical presentation, and we present the panel's consensus and areas of disagreement. Overall, four general recommendations were made: (i) individualize therapeutic decisions, including whether to use antiparasitic drugs, based on the number, location, and viability of the parasites within the nervous system; (ii) actively manage growing cysticerci either with antiparasitic drugs or surgical excision; (iii) prioritize the management of intracranial hypertension secondary to neurocysticercosis before considering any other form of therapy; and (iv) manage seizures as done for seizures due to other causes of secondary seizures (remote symptomatic seizures) because they are due to an organic focus that has been present for a long time.	en_US
dc.language.iso	eng
dc.publisher	American Society for Microbiology
dc.relation.ispartofseries	Clinical Microbiology Reviews
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject	Health Planning Guideline	en_US
dc.subject	Neurocysticercosis	en_US
dc.title	Current consensus guidelines for treatment of neurocysticercosis.	en_US
dc.type	info:eu-repo/semantics/review
dc.identifier.doi	https://doi.org/10.1128/CMR.15.4.747-756.2002
dc.relation.issn	1098-6618